Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Macrogenics Inc (MGNX)  
$14.96 0.74 (5.2%) as of 4:30 Wed 3/27


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 62,030,000
Market Cap: 927.97(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $4.48 - $21.47
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    : 10.5
Insider 3/6 Months : 11.1
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   MacroGenics is a biopharmaceutical company. Co.'s main pipeline program is MGC018, an antibody-drug conjugate that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. Co. is also developing enoblituzumab, an Fc-optimized monoclonal antibody that targets B7-H3 and molecules that target programmed cell death protein 1, a protein that is important in the regulation of the immune system's response to cancer. In addition, Co. is developing MGD024, a bispecific DART molecule that engages CD3 on immune effector cells to kill CD123-expressing cancer cells in certain hematological malignancies, including acute myeloid leukemia.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 150,000 350,000 2,394,399
Total Buy Value $0 $669,585 $1,722,425 $11,462,434
Total People Bought 0 1 1 2
Total Buy Transactions 0 1 2 11
Total Shares Sold 223,125 242,005 242,005 247,377
Total Sell Value $4,005,780 $4,196,090 $4,196,090 $4,228,483
Total People Sold 5 5 5 5
Total Sell Transactions 9 10 10 11
End Date 2023-12-28 2023-09-26 2023-03-28 2022-03-28

   
Records found: 286
  Page 1 of 12  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Peters Jeffrey Stuart Senior VP and General Counsel   •       –      –    2024-03-06 4 AS $21.50 $421,938 D/D (19,625) 8,895 -33%     
   Peters Jeffrey Stuart Senior VP and General Counsel   •       –      –    2024-03-06 4 OE $10.15 $213,875 D/D 19,625 28,520     -
   Karrels James SVP, CFO and Secretary   •       –      –    2024-03-04 4 AS $20.50 $615,000 D/D (30,000) 171,452 -30%     
   Spitznagel Thomas Sr VP, Technical Ops   •       –      –    2024-03-04 4 AS $20.00 $200,000 D/D (10,000) 8,316 -30%     
   Spitznagel Thomas Sr VP, Technical Ops   •       –      –    2024-03-04 4 OE $11.50 $115,000 D/D 10,000 18,316     -
   Risser Eric Blasius Chief Operating Officer   •       –      –    2024-03-04 4 AS $19.63 $813,501 D/D (41,159) 38,900 -30%     
   Risser Eric Blasius Chief Operating Officer   •       –      –    2024-03-04 4 OE $10.15 $152,250 D/D 15,000 80,059     -
   Peters Jeffrey Stuart Senior VP and General Counsel   •       –      –    2024-02-26 4 AS $17.22 $277,655 D/D (16,124) 8,895 -14%     
   Peters Jeffrey Stuart Senior VP and General Counsel   •       –      –    2024-02-22 4 D $17.11 $173,256 D/D (10,126) 25,019     -
   Peters Jeffrey Stuart Senior VP and General Counsel   •       –      –    2024-02-22 4 OE $0.00 $0 D/D 26,250 35,145     -
   Bonvini Ezio Sr VP, Research & CSO   •       –      –    2024-02-22 4 D $17.11 $160,252 D/D (9,366) 100,892     -
   Bonvini Ezio Sr VP, Research & CSO   •       –      –    2024-02-22 4 OE $0.00 $0 D/D 28,125 110,258     -
   Risser Eric Blasius Chief Operating Officer   •       –      –    2024-02-15 4 D $17.40 $102,295 D/D (5,879) 65,059     -
   Risser Eric Blasius Chief Operating Officer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 16,670 70,938     -
   Bonvini Ezio Sr VP, Research & CSO   •       –      –    2024-02-15 4 D $17.40 $102,155 D/D (5,871) 82,133     -
   Bonvini Ezio Sr VP, Research & CSO   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 16,670 88,004     -
   Cilinski Lynn VP, Controller and Treasurer   •       –      –    2024-02-15 4 D $17.40 $41,377 D/D (2,378) 6,213     -
   Cilinski Lynn VP, Controller and Treasurer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 6,668 8,591     -
   Eck Stephen L. Chief Medical Officer   •       –      –    2024-02-15 4 D $17.40 $119,573 D/D (6,872) 9,798     -
   Eck Stephen L. Chief Medical Officer   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 16,670 16,670     -
   Peters Jeffrey Stuart Senior VP and General Counsel   •       –      –    2024-02-15 4 D $17.40 $77,273 D/D (4,441) 8,895     -
   Peters Jeffrey Stuart Senior VP and General Counsel   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 13,336 13,336     -
   Karrels James SVP, CFO and Secretary   •       –      –    2024-02-15 4 D $17.40 $92,690 D/D (5,327) 201,452     -
   Karrels James SVP, CFO and Secretary   •       –      –    2024-02-15 4 OE $0.00 $0 D/D 15,003 206,779     -
   Koenig Scott President and CEO   •       •      –    2024-02-15 4 D $17.40 $249,673 D/D (14,349) 1,077,628     -

  286 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 12
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed